Versatile Endoscopic Capsule for gastrointestinal TumOr Recognition and therapy
  Funded by the European Commission, Sixth Framework Programme, Information Society Technologies Priority

  WP15 Derivatives & Spin-Off Devices

In order to ensure a proper transfer of the technology developed within the scope of the VECTOR project into future products, the project partners will work on derivative solutions of the smart capsule technology that can be employed into medical use during the pathway of the research program. For this purpose, the technology platforms of the smart capsule, e.g. those for locomotion, tissue manipulation, or tumor recognition, will be assessed according to their suitability, usability, requirements for immediate medical use, and medical indications by means of prototypes of derivative devices.
The derivative devices will be adapted to currently used medical procedures and methods, in order to obtain information about the said aspects, taking into account the medical reality. This process enables specific functions of the technology platforms for the smart capsule to be tested and verified in the medical world before the complete smart capsule system is available.

This information supports the project partners to continuously orientate the development process to the basic requirements by learning from the experiences collected with derivative devices. Thus, the work within the scope of the WP 15 serves as a constructive feedback mechanism and guideline to enable the project partners to optimize research pathway, apart from its genuine function to make VECTOR technology platforms available for medical use as soon as possible.

A further objective of the WP 15 is to maximize the exploitation of the R&D results by adapting derivative devices to neighboring medical applications. For this purpose, individual results of the development work are verified for medical usability by means of experimental prototypes of the respective derivative device. With this early technology transfer approach, the project partners are aiming at exploiting the R&D results for non-capsule applications as well. This also supports the communication with the clinical community through making derivative devices practically available among the users; thus the future medical introduction of smart capsules will be easier thanks to these technology platforms.

WP Leader
Ovesco Endoscopy AG, Germany

Endosmart GmbH, Germany
ERA Endoscopy Srl, Italy
University of Barcelona, Spain
FORTH Foundation for research and technologies Hellas, Greece